HomeNRSN • NASDAQ
add
Neurosense Therapeutics Ltd
Previous close
$0.76
Day range
$0.76 - $0.84
Year range
$0.63 - $2.60
Market cap
29.34M USD
Avg Volume
156.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.20M | 80.49% |
Net income | -3.21M | -78.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.19M | -80.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 166.00K | -95.09% |
Total assets | 1.03M | -77.53% |
Total liabilities | 2.59M | 29.92% |
Total equity | -1.56M | — |
Shares outstanding | 35.35M | — |
Price to book | -15.20 | — |
Return on assets | -777.36% | — |
Return on capital | 574.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.21M | -78.12% |
Cash from operations | -1.84M | — |
Cash from investing | 2.50K | — |
Cash from financing | 1.57M | — |
Net change in cash | -250.00K | — |
Free cash flow | -1.08M | — |
About
Founded
2017
Website
Employees
17
